Journal profile · PHARMACOLOGY & PHARMACY-TOXICOLOGY
Journal of Pharmacological and Toxicological Methods
ISSN 1056-8719 · eISSN 1873-488X · Elsevier Inc. · UNITED STATES
Journal of Pharmacological and Toxicological Methods: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.06; hybrid open access; APC about USD 3,500; median 101 days to acceptance (80 articles, last 24 months); community-reported acceptance: fairly easy; 307 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Pharmacological and Toxicological Methods is published by Elsevier Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cardiac electrophysiology and arrhythmias, Animal testing and alternatives and Neuroscience and Neural Engineering, together about 33.3% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Pharmacological and Toxicological Methods publishes original articles and reviews on methods for use in pharmacology and toxicology (including safety pharmacology). We are particularly interested in papers that focus on one or more of the following issues:New models of disease and approaches to drug discoveryValidation of modelsImprovement in the efficiency of techniques and assaysIdentification and mitigation against sources of experimental variationInterspecies comparisonsStatistical methodsNew technology for evaluation of drug activity (e.g. Including advances in imaging, imaging technology)New techniques for discovery of biologics (e.g. Immunotherapy)Non-biological assay methods
From the journal's Aims & Scope
Research area (LetPub): PHARMACOLOGY & PHARMACY-TOXICOLOGY
Editor-in-chief Noriko DaneshtalabPublisher website
Editorial board by country: none in mainland China; most named United States 14, United Kingdom 10, Canada 8, Australia 4, Serbia 2 (44 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cardiac electrophysiology and arrhythmiasMedicine21%
- Animal testing and alternativesVeterinary6.2%
- Neuroscience and Neural EngineeringNeuroscience6.1%
- Receptor Mechanisms and SignalingBiochemistry, Genetics and Molecular Biology5.3%
- Computational Drug Discovery MethodsComputer Science4.6%
- Ion channel regulation and functionBiochemistry, Genetics and Molecular Biology4.6%
- Neuroscience and Neuropharmacology ResearchNeuroscience4.2%
- 3D Printing in Biomedical ResearchEngineering3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
| Minor | Toxicology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
| Minor | Toxicology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
| Minor | Toxicology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.06LetPub ·
- Impact factor (publisher)
- 2.1Publisher website ·
- CiteScore 2026-06
- 3.8LetPub ·
- CiteScore (publisher)
- 3.8Publisher website ·
- SJR 2026-06
- 0.55LetPub ·
- SNIP 2026-06
- 1.01LetPub ·
- h-index
- 64LetPub ·
- h-index
- 100OpenAlex ·
- i10-index
- 1,323OpenAlex ·
- 2-year mean citedness
- 0.81OpenAlex ·
- Self-citation rate
- 14.3%LetPub ·
- Share of gold OA articles
- 23.78%LetPub ·
Volume
- Articles per year
- 44LetPub ·
Articles by year OpenAlex count · 5,321 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 159 | 24 | 20 |
| 2025 | 307 | 22 | 122 |
| 2024 | 69 | 23 | 291 |
| 2023 | 44 | 19 | 289 |
| 2022 | 55 | 21 | 420 |
| 2021 | 154 | 35 | 533 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
101 daysMedian, submission to acceptance · P25–P75 76 days – 155 days
- Acceptance to online
- median 3 days (80 articles)
- Submission to online
- median 105 days
- Sample
- 80 articles with submission and acceptance dates (91 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Submission to first decision
- 11 daysPublisher website ·
- First decision after review
- 65 daysPublisher website ·
- Submission to acceptance
- 97 daysPublisher website ·
- Acceptance to publication
- 4 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,500 / EUR 3,270 / GBP 2,800 / JPY 434,110 | — | — | |
| Publisher website | USD 3,730 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Reference style
- APA
- First submission
- Free format: the journal's layout is not required
Article types accepted9
- appraisal of state-of-the-art“Appraisal of state-of-the-art” or "Historical review” of particular models, methods, techniques or apparatusLength not stated
- brief communication“Original articles”: Characterization or validation of a disease model, method, technique, apparatus or approach to analysis of pharmacological or toxicological…Length not stated
- brief communications“Brief communications” detailing simple modifications of an existing model or methodLength not stated
- historical review“Appraisal of state-of-the-art” or "Historical review” of particular models, methods, techniques or apparatusLength not stated
- how to“How To” articles that provide step-by-step guidance on the execution of a specific techniqueLength not stated
- methods in drug discovery“Methods in drug discovery” – perhaps the most important category. Here, by showing how a method was used to select a drug that was eventually found to be clini…Length not stated
- original article“Original articles”: Characterization or validation of a disease model, method, technique, apparatus or approach to analysis of pharmacological or toxicological…Length not stated
- original articles“Original articles”: Characterization or validation of a disease model, method, technique, apparatus or approach to analysis of pharmacological or toxicological…Length not stated
- review“Original articles”: Characterization or validation of a disease model, method, technique, apparatus or approach to analysis of pharmacological or toxicological…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
File format Model summary
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Data availability
Data statement Model summary
To foster transparency, you are required to state the availability of any data at submission.
Source ↗Publisher website ·- Publication ethics
Publishing ethics policy Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Inc.
- Country or region
- UNITED STATES
- Language
- English
- ISSN
- 1056-8719
- Electronic ISSN
- 1873-488X
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Pharmacological and Toxicological Methods
What CAS zone is Journal of Pharmacological and Toxicological Methods in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Pharmacological and Toxicological Methods is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy / Toxicology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Pharmacological and Toxicological Methods?
The latest impact factor listed by LetPub is 2.06; CiteScore 3.8, h-index 100.
How long does peer review take at Journal of Pharmacological and Toxicological Methods?
Based on the dates recorded on 80 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 101 days (interquartile range 76–155 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Pharmacological and Toxicological Methods?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Reference style: APA; First submission: Free format: the journal's layout is not required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Pharmacological and Toxicological Methods based?
Of the 44 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (14), United Kingdom (10) and Canada (8). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Pharmacological and Toxicological Methods?
According to LetPub and DOAJ records, Journal of Pharmacological and Toxicological Methods is indexed in SCIE and Scopus.
Is Journal of Pharmacological and Toxicological Methods open access, and what is the APC?
Journal of Pharmacological and Toxicological Methods is a hybrid journal. For open-access publication: APC about USD 3,500.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .